Ureterovesical malignancy following renal transplantation: a case report.
We present a case of ureterovesical stenosis that developed in 2 of 203 renal transplant patients operated between 1997 and 2005 in our department. In the current case, an ureterovesical region tumor was identified 1.5 years after renal transplantation, while being operated for the correction of ureterovesical stenosis. This report sought to remind physicians about the possibility of a malignancy in patients with ureterovesical stenosis following renal transplantation.
Bakirtas
H
H
Department of Urology, S.B. Ankara Etlik Ihtisas Hospital, Ankara, Turkey. hasanbakirtas@hotmail.com
Guvence
N
N
Ozok
H U
HU
Ure
M
M
Eroglu
M
M
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011859:Radiography; D013997:Time Factors; D014516:Ureteral Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000473:pathology*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine